Therapy‐related B ‐lymphoblastic leukemia/lymphoma with MYC rearrangement and multisite involvement following chemotherapy for ovarian cancer

Puntos clave

• Multisite involvement in this therapy-related leukemia is particularly concerning, as it complicates treatment plans.
• The presence of MYC rearrangement indicates a more aggressive form of the disease, requiring careful monitoring.
• This analysis presents findings from a specific case, emphasizing the role of previous chemotherapy exposure.
• Awareness of such cases may enable more effective management strategies for similar future incidents.

Resumen